About the Authors
- Josep Gregori
-
* E-mail: josep.gregori@vhir.org
Affiliations Liver Unit, Internal Medicine, Lab. Malalties Hepàtiques, Vall d'Hebron Institut Recerca-Hospital Universitari Vall d'Hebron (VHIR-HUVH), Barcelona, Spain, Roche Diagnostics SL, Sant Cugat del Vallès, Spain
- Juan I. Esteban
-
Affiliations Liver Unit, Internal Medicine, Lab. Malalties Hepàtiques, Vall d'Hebron Institut Recerca-Hospital Universitari Vall d'Hebron (VHIR-HUVH), Barcelona, Spain, CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain, Universitat Autònoma de Barcelona, Bellaterra, Spain
- María Cubero
-
Affiliations Liver Unit, Internal Medicine, Lab. Malalties Hepàtiques, Vall d'Hebron Institut Recerca-Hospital Universitari Vall d'Hebron (VHIR-HUVH), Barcelona, Spain, CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain
- Damir Garcia-Cehic
-
Affiliations Liver Unit, Internal Medicine, Lab. Malalties Hepàtiques, Vall d'Hebron Institut Recerca-Hospital Universitari Vall d'Hebron (VHIR-HUVH), Barcelona, Spain, CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain
- Celia Perales
-
Affiliations CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain, Centro de Biología Molecular Severo Ochoa (CBM), UAM, Madrid, Spain
- Rosario Casillas
-
Affiliations Liver Unit, Internal Medicine, Lab. Malalties Hepàtiques, Vall d'Hebron Institut Recerca-Hospital Universitari Vall d'Hebron (VHIR-HUVH), Barcelona, Spain, Biochemistry Unit, HUVH, Barcelona, Spain
- Miguel Alvarez-Tejado
-
Affiliation Roche Diagnostics SL, Sant Cugat del Vallès, Spain
- Francisco Rodríguez-Frías
-
Affiliations CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain, Universitat Autònoma de Barcelona, Bellaterra, Spain, Biochemistry Unit, HUVH, Barcelona, Spain
- Jaume Guardia
-
Affiliations Liver Unit, Internal Medicine, Lab. Malalties Hepàtiques, Vall d'Hebron Institut Recerca-Hospital Universitari Vall d'Hebron (VHIR-HUVH), Barcelona, Spain, CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain, Universitat Autònoma de Barcelona, Bellaterra, Spain
- Esteban Domingo
-
Affiliations CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain, Centro de Biología Molecular Severo Ochoa (CBM), UAM, Madrid, Spain
- Josep Quer
-
Affiliations Liver Unit, Internal Medicine, Lab. Malalties Hepàtiques, Vall d'Hebron Institut Recerca-Hospital Universitari Vall d'Hebron (VHIR-HUVH), Barcelona, Spain, CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain, Universitat Autònoma de Barcelona, Bellaterra, Spain
Competing Interests
J. Gregori and M. Alvarez-Tejado are employees of Roche Diagnostics Spain. M. Cubero was employer of Roche Diagnostics Spain. All other authors have no conflict of interest to declare. Roche Diagnostics Spain had no role in the study design, data collection, data analysis, data interpretation, or writing of the report, and does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: JQ J. Gregori JIE FR-F. Performed the experiments: MC DG-C CP RC. Analyzed the data: JQ JIE J. Gregori MA-T FRF ED J. Guardia. Contributed reagents/materials/analysis tools: J. Gregori MA-T. Wrote the manuscript: JQ J. Gregori JIE FR-F ED J. Guardia.